Although it is challenging to isolate the burden of TTR-HO from the general medical burden following tumor and treatment, TTR-HO is a distinct indication with unique challenges for those who experience rapid and persistent weight gain resulting from hypothalamic damage. Here, TTR is linked to neoplasm.